Skip to content

Beta Bionics vs Hedia

Beta Bionics logo

Beta Bionics

Working to improve the lives of people living with diabetes and help reduce the data and decision-making overload

255 employees · est. 2015 · Irvine, United States

VS
Hedia logo

Hedia

Our vision is to improve quality of life for people with diabetes and make the best diabetes management tools available

43 employees · est. 2015 · Denmark

Beta Bionics is the larger of the two.

Side-by-Side Comparison

Beta Bionics Hedia
Founded
2015 2015
Headquarters
Irvine, United States Denmark
Employees
255 larger 43
Industry
Biotechnology, Medical Devices AI, Life Sciences, Medical Devices
Funding Stage
Series D Seed
Total Funding
$293.45M $35.07M
Funding Rounds
8 7
Services
Not tracked yet Development and distribution of the Hedia Diabetes Assistant, a class IIb medical device designed to support the management of insulin-requiring diabetes. Additionally, collaboration with partners in the diabetes ecosystem.
Target Customers
Not tracked yet Patients with insulin-requiring diabetes, healthcare professionals, clinics, hospitals, and industry leaders within the diabetes care space.
Taxonomy
Diabetes ManagementInsulin Delivery SystemGlucose MetabolismBionic PancreasPublic Benefit CorporationCertified B Corporation +6 Diabetes ManagementMedical DeviceHealthcare Professionals EducationInsulin RecommendationsPatient-Centric SolutionPersonalized Healthcare +4
Website
betabionics.com hedia.com
Beta Bionics logo

About Beta Bionics

Beta Bionics is a biotechnology and medical devices startup founded in 2015, based in the United States. The company's slogan embodies its mission of improving the lives of people living with diabetes and alleviating the burden of data and decision-making overload. Beta Bionics is focused on develop...

Hedia logo

About Hedia

Hedia is a Danish startup with a vision to improve the quality of life for people with diabetes by making the best diabetes management tools accessible to a wider audience. Their flagship product, the Hedia Diabetes Assistant (HDA), is a class IIb medical device designed to enhance the management of...

Also comparing in this category

Comparing more than these two?

Get Beta Bionics, Hedia and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Beta Bionics compare?

A PDF of Beta Bionics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Beta Bionics was founded in 2015, based in Irvine, United States, with 255 employees. Beta Bionics is a biotechnology and medical devices startup founded in 2015, based in the United States. The company's slogan embodies its mission of improving the lives of people living with diabetes. Hedia was founded in 2015, based in Denmark, with 43 employees. Hedia is a Danish startup with a vision to improve the quality of life for people with diabetes by making the best diabetes management tools accessible to a wider audience. Their flagship product, the.
Beta Bionics has raised $293.45M and Hedia $35.07M. Latest stage: Beta Bionics Series D, Hedia Seed.
Both work in Medical Devices and list diabetes management among their focus areas.

Compare Beta Bionics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Beta Bionics on 11 Sep 2024, and Hedia on 24 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout